Insights

Strategic M&A signals Obagi is navigating a high-profile ownership and leadership transition with Bridgepoint involvement and key executives from Waldencast joining. This indicates potential for refreshed go-to-market strategies, expanded distribution, and cross-brand collaboration opportunities that sales teams can leverage to open new channels and accelerate product adoption.

Geographic footprint expansion The company distributes in over 42 countries and continues to expand its international partnerships. This opens opportunities to pursue regional dermal and aesthetic clinics, medispas, and distributors in emerging markets where similar premium skincare systems have demand but limited direct access.

Product portfolio focus Obagi emphasizes physician-dispensed topical aesthetic and therapeutic skin care systems addressing photodamage, hyperpigmentation, acne, and sun damage. Sales prospects exist in dermatology practices, plastic surgery centers, and specialty clinics seeking comprehensive, clinically-proven regimens for patient results.

Regulatory and legal context Recent class action and labor-related developments present potential reputational and operational risk but also signals the need for programmatic compliance offerings, training services, and improved employer-education solutions that can be bundled with enterprise accounts as risk-mitigation value adds.

Valuation and focus on growth markets With a recent valuation context around Obagi within Waldencast and a 2025 Japan rights sale, sales teams should identify growth-market opportunities, licensing, and regional partnerships that optimize profitability while expanding market share in premium skincare.

Similar companies to Obagi

Obagi Tech Stack

Obagi uses 8 technology products and services including Microsoft Advertising, Adobe Creative Cloud, Tableau, and more. Explore Obagi's tech stack below.

Media & News

Obagi's Email Address Formats

Obagi uses at least 4 email formats:
Obagi Email FormatsExamplePercentage
First.Last@obagi.comJohn.Doe@obagi.com
55%
FirstL@obagi.comJohnD@obagi.com
38%
Last.First@obagi.comDoe.John@obagi.com
4%
F-Last@obagi.comJ-Doe@obagi.com
3%

Frequently Asked Questions

What is Obagi's phone number?

Minus sign iconPlus sign icon
You can contact Obagi's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Obagi's stock symbol?

Minus sign iconPlus sign icon
Obagi is a publicly traded company; the company's stock symbol is OMPI.

What is Obagi's official website and social media links?

Minus sign iconPlus sign icon
Obagi's official website is obagi.com and has social profiles on LinkedIn.

How much revenue does Obagi generate?

Minus sign iconPlus sign icon
As of October 2026, Obagi's annual revenue is estimated to be $500M - $1B.

What is Obagi's SIC code and NAICS code?

Minus sign iconPlus sign icon
Obagi's SIC code is 2834 - Pharmaceutical Preparations and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Obagi have currently?

Minus sign iconPlus sign icon
As of October 2026, Obagi has approximately 496 employees across 5 continents, including North America, Asia and Africa. Key team members include President: W. C., Head Of Marketing: Y. P. and Head Of Marketing Communications: L. K. Explore Obagi's employee directory with LeadIQ.

What industry does Obagi belong to?

Minus sign iconPlus sign icon
Obagi operates in the Pharmaceutical Manufacturing industry.

What technology does Obagi use?

Minus sign iconPlus sign icon
Obagi's tech stack includes Microsoft Advertising, Adobe Creative Cloud, Tableau, Figma, NetSuite, Atlassian Jira, monday.com and Microsoft Teams.

What is Obagi's email format?

Minus sign iconPlus sign icon
Obagi's email format typically follows the pattern of First.Last@obagi.com. Find more Obagi email formats with LeadIQ.

When was Obagi founded?

Minus sign iconPlus sign icon
Obagi was founded in 1988.
Obagi logo

Obagi

Pharmaceutical ManufacturingCalifornia, United States201-500 Employees

Obagi Cosmeceuticals is a specialty pharmaceutical company focused on developing, marketing, and selling proprietary topical skincare systems designed to prevent and improve common and visible skin conditions. Its product portfolio targets dermatology, plastic surgery, and related aesthetic markets, addressing issues such as photodamage, hyperpigmentation, sun damage, and acne. Founded in 1988 with the Obagi Nu-Derm System and operating as Obagi Medical from 1997, the company is headquartered in Long Beach, California, United States, and sells through a direct US sales force and distribution partners in more than 42 countries.

The firm employs a few hundred people. It operates in the pharmaceutical manufacturing industry, positioning itself in physician-dispensed skincare. In May 2026, Obagi launched The Skin Recharge Station, a limited-time pop-up experience, in partnership with Next Health, blending advanced skincare with wellness.

Section iconCompany Overview

Phone number
Website
obagi.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
OMPI
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1988
Employees
201-500

Section iconFunding & Financials

  • $500M - $1B

    Obagi's revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.